BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12079225)

  • 21. Cutaneous lymphomas: from morphology to chip technology.
    Cerroni L; Wiesner T
    Actas Dermosifiliogr; 2009 Nov; 100 Suppl 1():3-17. PubMed ID: 20096193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.
    Han B; Liu H; Wang H
    Dermatol Ther; 2022 Nov; 35(11):e15812. PubMed ID: 36088631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enzyme cytochemical and immunological procedures for diagnosis of pseudolymphomas and skin lymphomas].
    Burg G
    Z Hautkr; 1980 Oct; 55(20):1351-66. PubMed ID: 6970461
    [No Abstract]   [Full Text] [Related]  

  • 25. Histomorphology and cytomorphology of cutaneous B-cell lymphomas.
    Kerl H; Burg G
    J Dermatol Surg Oncol; 1984 Apr; 10(4):266-70. PubMed ID: 6608538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinicopathologic features of primary hepatic marginal zone lymphoma of mucosa-associated lymphoid tissue and hepatic pseudolymphoma].
    Liu C; Li X; Li H; Gong QX; Li Y; Wang Z; Zhang ZH
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):39-44. PubMed ID: 29325249
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous manifestations of lymphoma: a clinical guide based on the WHO classification. World Health Organization.
    Sander CA; Flaig MJ; Jaffe ES
    Clin Lymphoma; 2001 Sep; 2(2):86-100; discussion 101-2. PubMed ID: 11707848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous pseudolymphomas: inflammatory reactive proliferations.
    Hussein MR
    Expert Rev Hematol; 2013 Dec; 6(6):713-33. PubMed ID: 24191857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Report of the symposium on Cutaneous Lymphomas: Sixth International Conference on Malignant Lymphoma.
    Jaffe ES; Burg G
    Ann Oncol; 1997; 8 Suppl 1():83-4. PubMed ID: 9187437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced number of CD1a+ cells in cutaneous B-cell lymphoma.
    Schmuth M; Sidoroff A; Danner B; Topar G; Sepp NT
    Am J Clin Pathol; 2001 Jul; 116(1):72-8. PubMed ID: 11447755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary cutaneous B-cell lymphoma: a clinically homogeneous entity?
    Pimpinelli N; Santucci M; Mori M; Vallecchi C; Giannotti B
    J Am Acad Dermatol; 1997 Dec; 37(6):1012-6. PubMed ID: 9418781
    [No Abstract]   [Full Text] [Related]  

  • 32. Significance of non-lymphoid ('accessory') cells in malignant lymphomas and pseudolymphomas of the skin.
    Smolle J; Kaudewitz P; Burg G; Kresbach H; Kerl H
    Br J Dermatol; 1985 Dec; 113(6):677-85. PubMed ID: 3913456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermoscopy of primary cutaneous B- and T-cell lymphomas and pseudolymphomas presenting as solitary nodules and tumors: a case-control study with histopathologic correlation.
    Navarrete-Dechent C; Del Puerto C; Abarzúa-Araya Á; Molgó M; Geller S; Andreani S; Cury-Martins J; Sanches JA; Montoya J; González S; Uribe P
    Int J Dermatol; 2019 Nov; 58(11):1270-1276. PubMed ID: 31347153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
    Slater DN
    Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The skin-associated lymphoid tissue-related B-cell lymphomas.
    Pimpinelli N; Santucci M
    Semin Cutan Med Surg; 2000 Jun; 19(2):124-9. PubMed ID: 10892714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.
    Goyal A; Moore JB; Gimbel D; Carter JB; Kroshinsky D; Ferry JA; Harris NL; Duncan LM
    J Cutan Pathol; 2015 Jan; 42(1):6-15. PubMed ID: 25384543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic difficulties in 'non-mycotic' cutaneous lymphoproliferative diseases.
    Slater DN
    Histopathology; 1992 Sep; 21(3):203-13. PubMed ID: 1398519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [WHO and European Organization for Research and Treatment of Cancer (EORTC) classification of cutaneous lymphoma].
    Liu WP; Li GD
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):133-5. PubMed ID: 17493392
    [No Abstract]   [Full Text] [Related]  

  • 39. Primary cutaneous marginal zone B-cell lymphoma: clinical and histological aspects.
    Khaled A; Sassi S; Fazaa B; Ben Hassouna J; Ben Romdhane K; Kamoun MR
    Pathologica; 2009 Feb; 101(1):18-20. PubMed ID: 19771768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Merkel cell polyomavirus DNA in cutaneous lymphomas, pseudolymphomas, and inflammatory skin diseases.
    Andres C; Puchta U; Sander CA; Ruzicka T; Flaig MJ
    Am J Dermatopathol; 2010 Aug; 32(6):593-8. PubMed ID: 20534985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.